Corporate Finance M&A Deals Old Articles
A Twisted Deal Structure: Johnson & Johnson to Acquire Actelion for $30bn in Cash
Johnson & Johnson (NYSE: JNJ) — market cap as of 10/02/2017: $310.36bn Actelion (VTX: ATLN) – market cap as of 10/02/2017: CHF 28.13bn Introduction On the January 26, 2017, the US healthcare behemoth Johnson & Johnson announced the acquisition of the Swiss biotech company Actelion for $30bn in cash. Read more…